These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34303789)
41. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells. McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645 [TBL] [Abstract][Full Text] [Related]
42. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction. Fujii H; Goto S; Fukagawa M Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660 [TBL] [Abstract][Full Text] [Related]
43. Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis. Jourde-Chiche N; Burtey S Kidney Int; 2020 Jun; 97(6):1102-1104. PubMed ID: 32444090 [TBL] [Abstract][Full Text] [Related]
49. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease. Black AP; Cardozo LF; Mafra D Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II. Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537 [TBL] [Abstract][Full Text] [Related]
51. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Wu CL; Tarng DC Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312 [TBL] [Abstract][Full Text] [Related]
52. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment. Jang Y; Rao X; Jiang Q J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081 [TBL] [Abstract][Full Text] [Related]
53. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease. Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039 [TBL] [Abstract][Full Text] [Related]
54. Role of Uremic Toxins in Early Vascular Ageing and Calcification. Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534 [TBL] [Abstract][Full Text] [Related]
55. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β Yamamoto S Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756 [TBL] [Abstract][Full Text] [Related]
56. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury. Caillard P; Bennis Y; Six I; Bodeau S; Kamel S; Choukroun G; Maizel J; Titeca-Beauport D Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622583 [TBL] [Abstract][Full Text] [Related]
57. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Motojima M; Hosokawa A; Yamato H; Muraki T; Yoshioka T Kidney Int; 2003 May; 63(5):1671-80. PubMed ID: 12675842 [TBL] [Abstract][Full Text] [Related]